0.025% Capsaicin Gel for the Treatment of Painful Diabetic Neuropathy: A Randomized, Double-Blind, Crossover, Placebo-Controlled Trial

Pain Practice

Volumn 13, Issue 6, 2013, Pages 497-503

  Kulkantrakorn, Kongkiat ^a   Lorsuwansiri, Chakraphong ^a   Meesawatsom, Pongsatorn ^b  

^a THAMMASAT UNIVERSITY   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Capsaicin; Diabetic neuropathy; Neuropathic pain; Topical gel

Indexed keywords

AMITRIPTYLINE; CAPSAICIN; CAPSIKA; GABAPENTIN; NORTRIPTYLINE; PARACETAMOL; PLACEBO; PREGABALIN; TRAMADOL; UNCLASSIFIED DRUG;

ADULT; AGED; ANALGESIA; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIABETIC NEUROPATHY; DISEASE SEVERITY; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; ERYTHEMA; FEMALE; HEADACHE; HUMAN; HYPERTENSION; INTENTION TO TREAT ANALYSIS; MALE; MCGILL PAIN QUESTIONNAIRE; NAUSEA; NEUROPATHIC PAIN; NEUROPATHIC PAIN SCALE; PAPULE; RANDOMIZED CONTROLLED TRIAL; SKIN BURNING SENSATION; SKIN EDEMA; SKIN MANIFESTATION; SKIN PRURITUS; TREATMENT OUTCOME; VISUAL ANALOG SCALE; VOMITING;

EID: 84880045005     PISSN: 15307085     EISSN: 15332500     Source Type: Journal    
DOI: 10.1111/papr.12013     Document Type: Article

References (19)

1. Dyck PJ, Albers JW, Andersen H, et al. Diabetic polyneuropathies: update on research definition, diagnostic criteria and estimation of severity. Diabetes Metab Res Rev. 2011 Jun 21. doi: 10.1002/dmrr.1226. [Epub ahead of print].
2. Tesfaye S, Vileikyte L, Rayman G, et al. Painful diabetic peripheral neuropathy: consensus recommendations on diagnosis, assessment and management. Diabetes Metab Res Rev. 2011 Jun 21. doi: 10.1002/dmrr.1225. [Epub ahead of print].
3. Baron R, Tolle TR, Gockel U, Brosz M, Freynhagen R. A cross-sectional cohort survey in 2100 patients with painful diabetic neuropathy and postherpetic neuralgia: differences in demographic data and sensory symptoms. Pain. 2009;146:34-40.
4. Petrikonis K, Sciupokas A, Samušyte G, Janušauskaite J, Sulcaite R, Vaitkus A. Importance of pain evaluation for more accurate diagnosis of painful diabetic polyneuropathy. Medicina (Kaunas). 2010;46:735-742.
5. Attal N, Cruccu G, Baron R, et al. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. Eur J Neurol. 2010;17:1113-e1188.
6. Davies M, Brophy S, Williams R, Taylor A. The prevalence, severity, and impact of painful diabetic peripheral neuropathy in type 2 diabetes. Diabetes Care. 2006;29:1518-1522.
7. daCosta DiBonaventura M, Cappelleri JC, Joshi AV. A longitudinal assessment of painful diabetic peripheral neuropathy on health Status, productivity, and health care utilization and cost. Pain Med. 2011;12:118-126.
8. Markovits E, Gilhar A. Capsaicin-an effective topical treatment in pain. Int J Dermatol. 1997;36:401-404.
9. Cortright DN, Szallasi A. Biochemical pharmacology of the vanilloid receptor TRPV1. An update. Eur J Biochem. 2004;271:1814-1819.
10. Anand P, Bley K. Topical capsaicin for pain management: therapeutic potential and mechanisms of action of the new high-concentration capsaicin 8% patch. Br J Anaesth. 2011;107:490-502.
11. Biesbroeck R, Bril V, Hollander P, et al. A double-blind comparison of topical capsaicin and oral amitriptyline in painful diabetic neuropathy. Adv Ther. 1995;12:111-120.
12. Tandan R, Lewis GA, Krusinski PB, Badger GB, Fries TJ. Topical capsaicin in painful diabetic neuropathy: controlled study with long-term follow-up. Diabetes Care. 1992;15:8-14.
13. The Capsaicin Study Group. Treatment of painful diabetic neuropathy with topical capsaicin. A multicenter, double-blind, vehicle-controlled study. Arch Intern Med. 1991;151:2225-2229.
14. Chaudakshetrin P, Prateepawanich P, Chira-Adisai W, Tassanawipas W, Leechavengvongs S, Kitisomprayoonkul W. Cross-cultural adaptation to the Thai language of the neuropathic pain diagnostic questionnaire (DN4). J Med Assoc Thai. 2007;90:1860-1865.
15. Kaur H, Hota D, Bhansali A, Dutta P, Bansal D, Chakrabarti A. A comparative evaluation of amitryptyline and duloxetine in painful diabetic neuropathy: a randomized, double-blind, cross-over clinical trial. Diabetes Care. 2011;34:818-822.
16. Senn S, ed. Cross-Over Trials in Clinical Research, 2nd ed. New York: John Wiley & Sons; 2002.
17. Bril V, England J, Franklin GM, et al. Evidence-based guideline: treatment of painful diabetic neuropathy. Report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation. Neurology.. 2011;76:1758-1765.
18. Kosuwan W, Sirichartiwapee S, Wisanuyotin T, Jeeravipoolvarn P, Laupattarakasem W. Efficacy of symptomatic control of knee osteoarthritis with 0.0125% of capsaicin versus placebo. J Med Assoc Thai. 2010;93:1188-1195.
19. Jorge LL, Feres CC, Teles VEP. Topical preparations for pain relief: efficacy and patient adherence. J Pain Res. 2010;4:11-24.